Medicines News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.05.19	The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress (Businesswire)
18.05.19	New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol with No Material Safety Observations Out to Three Years (Businesswire)
10.05.19	The Medicines Company to Host Investor Conference Call and Webcast During National Lipid Association’s 2019 Scientific Sessions (Businesswire)
25.04.19	The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program (Businesswire)
18.04.19	The Medicines Company to Announce First Quarter 2019 Financial Results on April 25 (Businesswire)
27.06.18	The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following [Third] Review of Unblinded Data (Businesswire)
26.06.18	New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce the Potential of The Medicines Company’s inclisiran in Patients with Diabetes (Businesswire)
07.05.18	The Medicines Company Announces Inclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke (Businesswire)
30.04.18	The Medicines Company Presents New Data at the National Lipid Association Scientific Sessions (Businesswire)
25.04.18	The Medicines Company Reports First-Quarter 2018 Results (Businesswire)
19.04.18	The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25 (Businesswire)
09.03.18	FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month (RTTNews)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
08.01.18	Sanofi And Alnylam Restructure RNAi Therapeutics Rare Disease Alliance (RTTNews)
29.11.17	Medicines Co. To Sell Infectious Disease Business Unit To Melinta Therapeutics (RTTNews)
29.11.17	Deerfield Supports Melinta Therapeutics Acquisition of The Medicines Company's Infectious Disease Business with a $240 million Commitment to Melinta and a $100 million Commitment to The Medicines... (PR Newswire)
06.11.17	Medicines Co., Alnylam Pharma Initiate Phase III Clinical Trial Of Inclisiran (RTTNews)
07.09.17	New Drugs Approved In August (RTTNews)
31.08.17	AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears (RTTNews)
30.08.17	Medicines Co.'s VABOMERE Approved By FDA For Adult Patients With CUTI (RTTNews)
28.08.17	Medicines Co. Announces New Data From ORION-1 Phase II Study Of Inclisiran (RTTNews)
21.08.17	Generic Drugs Stock Performance Review -- Patheon, Zoetis, Ironwood Pharma, and Medicines Co. (PR Newswire)
26.07.17	Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX (RTTNews)
19.07.17	Technical Reports on Generic Drugs Equities -- Allergan, Ironwood Pharma, Medicines Co., and Catalent (PR Newswire)
12.06.17	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma (PR Newswire)
06.06.17	Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S. (RTTNews)
04.06.17	Medicines Co. To Cut 15% Of Workforce As It Discontinues IONSYS In The U.S. (RTTNews)
01.05.17	How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
28.03.17	Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
20.03.17	AMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA Contract (RTTNews)
03.03.17	Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose (PR Newswire)
06.02.17	ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e) (RTTNews)
30.01.17	Generic Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett (PR Newswire)
09.01.17	EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data (RTTNews)
20.12.16	How These Generic Drugs Stocks are Faring? -- Ironwood Pharma, Medicines, Lannett, and SCYNEXIS (PR Newswire)
08.11.16	MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It's Time To Cherish IONS (RTTNews)
06.10.16	ALNY's ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move (RTTNews)
15.06.16	CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race (RTTNews)
03.06.16	AKAO Abuzz, AAAP Gets FDA Blessing, CORT Under Close Watch, Big Day For MBRX (RTTNews)
27.05.16	TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data (RTTNews)
09.05.16	Medicines Company To Divest Non-Core Cardiovascular Assets - Quick Facts (RTTNews)
04.04.16	The Medicines Company Announces Participation at 2016 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held April 9-12 in Amsterdam (Businesswire)
18.12.15	Medicines Co. To Sell Its Hemostatis Portfolio To Mallinckrodt - Quick Facts (RTTNews)
01.09.15	MATRIX Trial Results Presented at Hot Line Session of ESC Congress 2015 and Simultaneously Published in The New England Journal of Medicine (Businesswire)
01.09.15	Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach (Businesswire)
30.08.15	ALN-PCS Phase 1 Clinical Trial Shows Positive Results (RTTNews)
24.08.15	The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London (Businesswire)
09.07.15	Medicines Co. Authorizes Generic Launch Of Angiomax (RTTNews)
23.06.15	FDA Approves Medicines Co.'s Antiplatelet Drug Used During Heart Procedure (RTTNews)
01.06.15	The Medicines Company Announces Results of Phase 1 Study for Novel Investigational Intravenous Anesthetic, ABP-700 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

25.11.19		Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf
19.11.19		Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

25.11.19

Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf

19.11.19

Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	26.52	1.18 %	K V
ABB	47.84	1.10 %	K V
CieFinRichemont	159.70	1.01 %	K V
Givaudan	4’167.00	0.82 %	K V
Geberit	606.20	0.66 %	K V
Alcon	71.96	-0.61 %	K V
Roche Hldg G	260.90	-0.61 %	K V
Sonova Hldg	263.10	-0.64 %	K V
Kuehne+Nagel Int	188.90	-0.76 %	K V
Zurich Insur Gr	582.00	-0.85 %	K V

Medicines Aktie VALOR 1114748 / ISIN US5846881051

Nachrichten zu Medicines Co.

Aktien Top/Flop

Medicines Peer Group Nachrichten

Meistgelesene Nachrichten